/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} Problem 4 Tetrahydrolipstatin (Orlistat) i... [FREE SOLUTION] | 91Ó°ÊÓ

91Ó°ÊÓ

Tetrahydrolipstatin (Orlistat) is a drug treatment for obesity. It is an inhibitor of pancreatic lipase. Suggest a rationale for use of tetrahydrolipstatin to treat obesity.

Short Answer

Expert verified
Tetrahydrolipstatin (Orlistat) serves as an effective treatment for obesity due to its ability to inhibit the function of pancreatic lipase, an enzyme responsible for fat digestion. By preventing the breakdown and consequently the absorption of fats, the drug helps reduce caloric intake, thereby enabling weight loss.

Step by step solution

01

Understand Tetrahydrolipstatin (Orlistat)

Investigate Tetrahydrolipstatin, also known as Orlistat. This is a drug utilised in obesity treatment. Discover how it functions from a biochemical perspective.
02

Understand the purpose of Pancreatic Lipase

Delve into the function of pancreatic lipase. This enzyme is secreted by the pancreas and plays a crucial role in the digestive system by breaking down fats into smaller molecules that can be absorbed by the body.
03

Understand the interaction between Tetrahydrolipstatin and Pancreatic Lipase

Study how Tetrahydrolipstatin imposes on pancreatic lipase's function. It serves as an inhibitor to pancreatic lipase, preventing this enzyme from effectively breaking down fats. As a result, less fat is absorbed by the body and more is excreted from the body, thus aiding in weight loss.
04

Rationalize the use of Tetrahydrolipstatin (Orlistat) to treat obesity

Given the understanding from previous steps, form a rationale for using Tetrahydrolipstatin as a treatment for obesity. Because it prevents the breakdown and absorption of fats by inhibiting the action of pancreatic lipase, it helps to reduce calorie intake, which is a key factor in weight management.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

(a) Draw a general pathway for converting carbohydrates to fatty acids in a liver cell, and indicate which processes occur in the cytosol and which occur in mitochondria. (b) About half the reducing equivalents necessary for fatty acid synthesis are generated by glycolysis. Explain how these reducing equivalents can be used for fatty acid synthesis.

Where is the labeled carbon found when the following molecules are added to a liver homogenate carrying out palmitate synthesis? (a) \(\mathrm{H}^{14} \mathrm{CO}_{3}\) (b) \(\mathrm{O}\) \(\|\) \(\mathrm{H}_{3}{ }^{14} \mathrm{C}-\mathrm{C}-\mathrm{S}-\mathrm{CoA}\)

(a) Familial hypercholesterolemia is a human genetic disorder in which LDL receptors are defective, leading to very high blood cholesterol levels and severe atherosclerosis at an early age. Explain why this disease results in high blood cholesterol levels. (b) Do high blood cholesterol levels affect cellular cholesterol synthesis in individuals with this disease? (c) Individuals with Tangier's disease lack the cellular protein \(\mathrm{ABCl}\), which is required for cholesterol uptake by HDL. How will this disease affect cholesterol transport?

Excess dietary fat can be converted to cholesterol in the liver. When palmitate labeled with \({ }^{14} \mathrm{C}\) at every oddnumbered carbon is added to a liver homogenate, where does the label appear in mevalonate?

Animals cannot carry out a net conversion of even chain fatty acid carbons to glucose. On the other hand, some of the carbons in odd-chain fatty acids can be gluconeogenic precursors to glucose. Explain.

See all solutions

Recommended explanations on Chemistry Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.